Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000899243-22-007066

Chief Financial Officer sold 9,204 shares at $2.31 ($21,261)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Moran Kyle Chief Financial Officer 2022-02-16 Sale −9,204 $2.31 $21,261 74,588 D
Open-market sales · 9,204 sh · avg $2.31 · $21,261
Loading xslF345X03/doc4.xml…